Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis.
Ge P, Han C, Reyila A, Liu D, Hong W, Liu J, Zhang J, Han X, Li X, Huang M, Fan S, Kaierdebieke A, Wu X, Huang X, Guo W, Liu S, Bian Y.
Ge P, et al. Among authors: bian y.
Medicine (Baltimore). 2023 Sep 1;102(35):e34793. doi: 10.1097/MD.0000000000034793.
Medicine (Baltimore). 2023.
PMID: 37657052
Free PMC article.